SLC31A1 and non-small cell lung carcinoma: The expression levels of anti-COPT1 autoantibodies in plasma were further detected in the verification group (321 NSCLC, 321 BPN and 321 NC) to validate previous findings and enhanced the robustness of the results (Table 2).